Press Releases
April 28, 2021
Panbela Schedules Conference Call on May 12, 2021 to Report 2021 First Quarter Financial Results
April 15, 2021
Panbela Announces Partial Clinical Hold Lifted on Phase I Polyamine Metabolic Inhibitor Study in Pancreatic Cancer
April 6, 2021
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
March 25, 2021
Panbela Provides Business Update and Reports Q4 and FY 2020 Financial Results
March 18, 2021
Panbela Schedules Conference Call on March 25, 2021 to Report 2020 Fourth Quarter Financial Results
March 15, 2021
Panbela Appoints Industry Veteran, Garry A. Weems, PharmD, as Vice President of Clinical Development & Medical Affairs
March 8, 2021
Panbela to Participate in Upcoming Virtual Investor Conferences
February 10, 2021
Panbela Announces Research Agreement with Johns Hopkins University School of Medicine
February 10, 2021
Panbela Provides Update on Current Clinical Trial: Decision to Hold Administration of SBP-101
December 8, 2020
PBLA Completes Enrollment in Phase 1b Trial Investigating SBP-101 Combination Therapy for First Line Metastatic Pancreatic Cancer
Events & Presentations